1. Clinical & Scientific Overview
Magnesium Citrate (TIP-MED-000386, Reference Code [10.10]-C116) is classified under
Vitamins, Minerals & Nutritional Supplements (Ch 10) as a Essential Intracellular Divalent Cation (Cofactor for >300 ATP-Dependent Enzymatic Reactions, Neuromuscular Excitability, Cardiac Rhythm & Bone Matrix).
Within the Indian regulatory and compendial framework, it is governed under Non-Schedule / OTC or Schedule K Permitted Preparation (Medical Supervision Recommended for High-Dose/Therapeutic Regimens).
Co-indexed constituent under primary monograph [10.10] (Oral Magnesium Salts (Magnesium Oxide, Citrate & Bisglycinate — Nutritional)). Representative Indian Market Examples (Edition 2.7 Ch 10 [10.10], p. 131): Krampoff (Alkem—Mg Bisglycinate + Vit E/Carnitine), MgD3 (Mg Glycinate/Oxide + Vit D3), Magvion, Magnekon (Mg Oxide 400 mg), Magnex-G; Parenteral: Magnesium Sulphate (MgSO4 50% w/v — 500 mg/mL ampoules) — Strengths & Dosage Forms: Oral Tablets / Capsules: Magnesium Oxide 400 mg (~240 mg elemental Mg, low 4–10% bioavailability, high osmotic laxative effect), Magnesium Citrate / Magnesium Glycinate (Bisglycinate) 100–250 mg elemental Mg (high bioavailability, minimal diarrhoea); Parenteral Injection: MgSO4 50% (1 g/2 mL)
Oral Tablets / Capsules: Magnesium Oxide 400 mg (~240 mg elemental Mg, low 4–10% bioavailability, high osmotic laxative effect), Magnesium Citrate / Magnesium Glycinate (Bisglycinate) 100–250 mg elemental Mg (high bioavailability, minimal diarrhoea); Parenteral Injection: MgSO4 50% (1 g/2 mL)
3. Mechanism of Action & Pharmacodynamics
Essential Intracellular Divalent Cation (Cofactor for >300 ATP-Dependent Enzymatic Reactions, Neuromuscular Excitability, Cardiac Rhythm & Bone Matrix) acting on target receptor/enzyme pathways in Vitamins, Minerals & Nutritional Supplements (Ch 10): clinical efficacy is mediated via Essential Intracellular Divalent Cation (Cofactor for >300 ATP-Dependent Enzymatic Reactions, Neuromuscular Excitability, Cardiac Rhythm & Bone Matrix) for Prevention and treatment of hypomagnesaemia (induced by chronic Proton Pump Inhibitors [pantoprazole/omeprazole >1 year], loop/thiazide diuretics [furosemide/chlorthalidone], alcoholism, or diabetic osmotic diuresis); nocturnal leg cramps in the elderly; migraine prophylaxis; adjunct in osteoporosis and constipation (Mg Oxide/Hydroxide); Parenteral MgSO4: Eclampsia/pre-eclampsia, torsades de pointes ventricular tachycardia, and life-threatening acute severe asthma..
4. Therapeutic Indications & Evidence-Supported Uses
- Prevention and treatment of hypomagnesaemia (induced by chronic Proton Pump Inhibitors [pantoprazole/omeprazole >1 year], loop/thiazide diuretics [furosemide/chlorthalidone], alcoholism, or diabetic osmotic diuresis)
- nocturnal leg cramps in the elderly
- migraine prophylaxis
- adjunct in osteoporosis and constipation (Mg Oxide/Hydroxide)
- Parenteral MgSO4: Eclampsia/pre-eclampsia, torsades de pointes ventricular tachycardia, and life-threatening acute severe asthma
🇮🇳 Jurisdiction & Indication Note: Indications and schedules reflect Indian compendial and regulatory records (CDSCO / Indian Pharmacopoeia & NFI / NLEM 2022). Where international reference labels (US FDA DailyMed / NCBI StatPearls) are cited for pharmacokinetic or mechanistic parameters, international approvals do not automatically imply CDSCO approval in India.
5. Educational Dosage Context, Formulations & Administration
Educational Dosing & Regimen Summary: General Adult Reference: Oral Supplementation / Leg Cramps / Deficiency: 200 mg to 400 mg Elemental Magnesium daily (in 1–2 divided doses). Follow physician prescription.
Administration & Meal Timing: Take WITH meals or at bedtime (taking with food improves absorption and reduces osmotic loose stools). | At bedtime (for nocturnal calf cramps and muscle relaxation/sleep) or divided with lunch and dinner.
6. Pharmacokinetics, Metabolism & Renal/Hepatic Adjustment
Follows class pharmacokinetic profile detailed in parent monograph [10.10].
Renal: STRICTLY RENAL-FUNCTION DEPENDENT! The kidneys are the sole route of regulatory magnesium excretion. Avoid all oral magnesium supplements and magnesium-containing antacids/laxatives (Milk of Magnesia, Gelusil, Cremaffin) if eGFR <30 mL/min! Hepatic: Safe.
Renal: STRICTLY RENAL-FUNCTION DEPENDENT! The kidneys are the sole route of regulatory magnesium excretion. Avoid all oral magnesium supplements and magnesium-containing antacids/laxatives (Milk of Magnesia, Gelusil, Cremaffin) if eGFR <30 mL/min! Hepatic: Safe.
Renal: STRICTLY RENAL-FUNCTION DEPENDENT! The kidneys are the sole route of regulatory magnesium excretion. Avoid all oral magnesium supplements and magnesium-containing antacids/laxatives (Milk of Magnesia, Gelusil, Cremaffin) if eGFR <30 mL/min! Hepatic: Safe.
7. Contraindications, Precautions & High-Risk Warnings
- STRICTLY CONTRAINDICATED in Severe Chronic Kidney Disease (eGFR <30 mL/min / ESRD), Myasthenia Gravis (magnesium blocks presynaptic acetylcholine release at the neuromuscular junction and precipitates acute respiratory paralysis!), and Heart Block (2nd/3rd degree AV block)!
Key Clinical Precautions: Renal: STRICTLY RENAL-FUNCTION DEPENDENT! The kidneys are the sole route of regulatory magnesium excretion. Avoid all oral magnesium supplements and magnesium-containing antacids/laxatives (Milk of Magnesia, Gelusil, Cremaffin) if eGFR <30 mL/min! Hepatic: Safe.
8. Adverse Effects Profile
- Osmotic loose stools / diarrhoea and abdominal cramping (most prominent with poorly absorbed Magnesium Oxide/Sulphate; minimal with chelated Magnesium Glycinate!).
- Hypermagnesaemia in Renal Impairment (Serum Mg2+ >2.5–4.0 mg/dL: loss of deep tendon reflexes [patellar areflexia at >4–5 mg/dL], flushing, hypotension, lethargy, somnolence, respiratory muscle paralysis, complete heart block, and cardiac arrest!).
9. Major Drug–Drug, Drug–Food & Drug–Herb Interactions
- Chelation Blockade (Space by ≥2–4 Hours!): Magnesium chelates and blocks absorption of Fluoroquinolones (ciprofloxacin, levofloxacin), Tetracyclines (doxycycline), Oral Bisphosphonates (alendronate), Levothyroxine, Gabapentin, and Integrase Inhibitors! Potentiates neuromuscular blockers and nifedipine hypotension
10. Clinical Monitoring, Patient Counselling & Storage
Clinical & Laboratory Monitoring: Monitor clinical parameters per parent monograph [10.10].
Pharmacist Patient Counselling Points:
- Patient Counselling Checklist: 1. Differentiate salts: If prescribed for muscle cramps or sleep without wanting loose motions, Magnesium Glycinate (Bisglycinate) is gentle on the bowel, whereas Magnesium Oxide draws water into the gut and acts as a laxative. 2. Keep a strict 2-to-4 hour gap from thyroid pills, antibiotics, and bone (bisphosphonate) tablets. 3. If an elderly patient has been taking Pantoprazole/Omeprazole AND Furosemide/Chlorthalidone for years and complains of severe night-time calf cramps, check Serum Magnesium and Potassium.
- Meal & Clock Timing Instruction: Take WITH meals or at bedtime (taking with food improves absorption and reduces osmotic loose stools). (At bedtime (for nocturnal calf cramps and muscle relaxation/sleep) or divided with lunch and dinner.)
- Missed Dose Protocol: Take with the next meal or bedtime; never double.
- Geriatric Dispensing Pearl: Always check eGFR before dispensing any Magnesium supplement (or Mg-containing antacid/laxative) to an elderly CGHS patient—in Stage 4–5 CKD, magnesium rapidly accumulates and causes lethargy, falls, and heart block.
Storage, Stability & Dispensing Safeguards: Store below 25°C–30°C in original moisture- and light-resistant packaging out of reach of children. Available forms: Oral Tablets / Capsules: Magnesium Oxide 400 mg (~240 mg elemental Mg, low 4–10% bioavailability, high osmotic laxative effect), Magnesium Citrate / Magnesium Glycinate (Bisglycinate) 100–250 mg elemental Mg (high bioavailability, minimal diarrhoea); Parenteral Injection: MgSO4 50% (1 g/2 mL)
11. Visual Pharmacology & Mechanism Diagram (svg-v339-01-adme-12-step-journey)
12. Authoritative References, Regulatory Sources & Editorial Disclaimer
Primary Compendial & Guideline Reference: Indian Pharmacopoeia (IP 2022) • NFI • CDSCO
Official Verification Portals: Indian Pharmacopoeia Commission (IPC) & National Formulary of India (NFI) • Central Drugs Standard Control Organization (CDSCO) • Ministry of Health & Family Welfare — NLEM 2022 • NCBI Bookshelf / StatPearls Pharmacology Reference • DailyMed (US FDA Official Prescribing Reference)
Last Medically & Pharmaceutically Reviewed: 2026-11-10 • Verification Status: VERIFIED_EDUCATIONAL_CONTENT
Educational & Clinical Disclaimer: This reference profile is published solely for pharmacy education, academic study, and professional clinical reference. It does not substitute for patient-specific clinical judgement, qualified specialist oncology/medical supervision, or official CDSCO/IP prescribing information. Never self-medicate with prescription, Schedule H/H1/X, NDPS, or oncology medicines.
13. Related Reference Monographs, Educational Guides & Visual Concept
💊 Related Pharmacological / Category Profiles
- [10.3] Vitamin B-Complex (Therapeutic B1, B2, B3, B5, B6, B7, B9, B12 Combinations) — Water-Soluble Coenzyme Vitamin Complex (Carbohydrate, Amino Acid
- [10.4] Multivitamins and Multiminerals — Comprehensive Micronutrient Supplement (Fat-Soluble Vitamins A, D
- [10.5] Calcium Carbonate (Typically Combined with Vitamin D3) — Inorganic Calcium Salt (40% Elemental Calcium—Highest Elemental Y
- [10.6] Calcium Citrate / Calcium Citrate Malate (CCM) — Organic Acid-Independent Soluble Calcium Salt (~21–24% Elemental